Creutzfeldt-Jakob disease in a post-COVID-19 patient: did SARS-CoV-2 accelerate the neurodegeneration?

Taha K AlloushAdel T AlloushYaser AbdelazeemHossam M ShokriKhaled O AbdulghaniAhmed Elzoghby

Published in: The Egyptian journal of neurology, psychiatry and neurosurgery (2023)

Putting in mind all the updated data on the pathogenesis of CJD and the immune responses to SARS-CoV-2, we can suggest that COVID-19 can lead to accelerated pathogenesis and exaggerated manifestations of this fatal neurodegenerative disease.

Keyphrases

sars cov
respiratory syndrome coronavirus
immune response
coronavirus disease
dendritic cells
electronic health record